fashion -WSS

fashion

author：hotspot 2025-09-06 03:17:37 - browse：169

From left, STAT's Allison DeAngelis, ALS advocate Cathy Collet, Yale's Gregg Gonsalves, Sick Cells' Ashley Valentine, and Canary Advisors' Jennifer McNary at a panel at the 2024 STAT Breakthrough Summit East. STAT

NEW YORK — Over 30 years ago, Gregg Gonsalves and other AIDS activists persuaded Congress to create the accelerated approval pathway, allowing regulators to speed access to drugs for thousands of dying patients.

These days, though, Gonsalves sounds uneasy — if not mournful — of the world he helped build.

“We’re approving drugs faster and faster — [the FDA is] one of the fastest regulatory agencies in the world — we know less and less about them, and we pay more and more for them,” said Gonsalves, now a professor at Yale, at STAT Breakthrough Summit East on Thursday. “So in that way, the system is not working. We basically put access out there as this talisman of hope, but we don’t compel the companies that give us answers about what these drugs do in our bodies.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Medicare Advantage insurers face 0.2% cut to 2025 payments

focus

WSS

Syphilis numbers in the United States reach record heights

Teach medical students about patients with intellectual disabilities

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Why sickle cell disease is getting the first CRISPR treatment

10 reasons why health care startups fail

After sickle

leisure time

fashion

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: The latest on Novavax, Merck, Bluebird

As demand for Covid shots wanes, Moderna seeks its next success

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pfizer plans to depart BIO

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why you shouldn’t ask, “What country has the best health care?”

Sports medicine is finally prioritizing gender equality

Pregnancy discrimination could be enabled by AI

hotspot

Leukemia patients are helped by Syndax's new type of therapy

Teach medical students about patients with intellectual disabilities

Merck, Johnson & Johnson CEOs will testify on high drug prices

Medicare drug price negotiation legal challenge met with skepticism

Teach medical students about patients with intellectual disabilities

FDA needs staff influx to meet gene therapy needs, Marks says

hotspot

Wikipedia

focus

hotspot